Physiological and pathological aspects of the clinical application of proteinase inhibitors.
D000707:Anaphylaxis / Q000188:drug therapy; D000818:Animals; D007611:Aprotinin / Q000502:physiology / Q000627:therapeutic use*; D001920:Bradykinin / Q000502:physiology; D002417:Cattle; D002543:Cerebral Hemorrhage / Q000188:drug therapy; D004285:Dogs; D004751:Enteritis / Q000188:drug therapy; D005342:Fibrinolysis / Q000187:drug effects / Q000502:physiology; D006168:Guinea Pigs; D006801:Humans; D007609:Kallidin; D007610:Kallikreins / Q000037:antagonists & inhibitors / Q000502:physiology; D007705:Kinins / Q000494:pharmacology / Q000502:physiology*; D051379:Mice; D010195:Pancreatitis / Q000188:drug therapy; D051381:Rats; D012771:Shock, Hemorrhagic / Q000188:drug therapy; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy
D007705:Kinins; D007609:Kallidin; D007611:Aprotinin; D007610:Kallikreins; D001920:Bradykinin